Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control
- 1 June 1996
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 347 (9014) , 1514-1518
- https://doi.org/10.1016/s0140-6736(96)90672-8
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- 1,5-Anhydro-D-glucitol Evaluates Daily Glycemic Excursions in Well-Controlled NIDDMDiabetes Care, 1995
- Statistics notes: Calculating correlation coefficients with repeated observations: Part 1--correlation within subjectsBMJ, 1995
- Serum 1,5-anhydroglucitol (1,5 AG): New clinical marker for glycemic controlDiabetes Research and Clinical Practice, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Is Serum Anhydroglucitol an Alternative to the Oral Glucose Tolerance Test for Diabetes Screening?Diabetic Medicine, 1993
- Glycation Products and the Pathogenesis of Diabetic ComplicationsDiabetes Care, 1992
- Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitolMetabolism, 1992
- Hemoglobin a1C— Infatuation or the Real Thing?New England Journal of Medicine, 1990
- Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemiaDiabetologia, 1990
- Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patientsDiabetologia, 1988